Complete Response to Full-Dose Sorafenib Treatment in an Elderly HCC Patient: a Case Report.

about

Complete Response to Full-Dose Sorafenib Treatment in an Elderly HCC Patient: a Case Report.

Item

http://www.wikidata.org/entity/Q41306344

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Complete Response to Full-Dose ...... ly HCC Patient: a Case Report.

@en

type

Item

label

Complete Response to Full-Dose ...... ly HCC Patient: a Case Report.

@en

prefLabel

Complete Response to Full-Dose ...... ly HCC Patient: a Case Report.

@en

P1476

Complete Response to Full-Dose ...... ly HCC Patient: a Case Report.

@en

P2093

G de Stefano

http://www.w3.org/2001/XMLSchema#string

N Farella

http://www.w3.org/2001/XMLSchema#string

V Iodice

http://www.w3.org/2001/XMLSchema#string

P2860

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Sunitinib versus sorafenib in advanced hepatocellular cancer: results of a randomized phase III trial.

Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma patients treated with sorafenib

The outcomes and safety of single-agent sorafenib in the treatment of elderly patients with advanced hepatocellular carcinoma (HCC).

Geriatric oncology research to improve clinical care

Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib.

Targeted therapy for advanced hepatocellular cancer in the elderly: focus on sorafenib.

Is the efficacy of sorafenib treatment in patients with hepatocellular carcinoma affected by age?

Sorafenib in advanced hepatocellular carcinoma: hypertension as a potential surrogate marker for efficacy.

New aspects of an anti-tumour drug: sorafenib efficiently inhibits HCV replication.

P2888

s12029-015-9720-5

P304

430-433

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12029-015-9720-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25894635

http://www.w3.org/2001/XMLSchema#string